Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The analysis of our own clinical data suggests that majority of the hematologic responses observed after the course of h-ATG/CsA is partial, and about 10% tend to have cyclosporine dependence. The aim of the current study is to improve the rate and the quality of hematologic response as well as to prevent delayed complications such as relapse and clonal progression by means of adding eltrombopag to standard immunosuppressive therapy
Epistemonikos ID: 6cad048845b0111d2da406854c3372fc8ab9d8ec
First added on: May 21, 2024